Participants from overseas may register for a poster presentation, an oral presentation, or both.
Please note that the Excellent Presentation Award and the Student Poster Award require JSOT membership.
In addition, including the JSOT International Poster Award, applicants may not apply for more than one award.

Please note that all the applicants are requested to complete the payment of registration fee by the deadline of abstract submission. If you do not complete the payment of registration fee, your abstract will be withdrawn.

• Oral/Poster Presentation

*The poster size should be 180cm long and 90cm wide or smaller.

Please check the Criteria of COI below; At the time of abstract submission, you have to choose appropriate status of COI. If you choose Yes, it has to declare COI related matter on the presentation slide and also submit it.
Please also disclose the status of COI if you have nothing to declare.

Disclosure method

For oral session, include a self-disclosure of the state of COI in the second slide (following the title slide). In case of poster presentation, please disclose financial relationships on your research in the poster, referring to the examples of disclosure in oral presentation.

Sample slides are available here.

All human and animal studies must have been approved by the authors' institutional review board. All clinical investigation must have been conducted according to Declaration of Helsinki principles. Keep subjects' personal information confidential.

An applicant must:

• be a member of the Japanese Society of Toxicology
• be under the age of 40 as of March 31, 2026
• be a presenter of poster presentation (Award applicants are to do an oral presentation also on July 1, 2026)
• be pre-registered for the Congress and complete the payment of registration fee by the deadline of abstract submission
• obtain a visa for entering Japan prior to the Congress, if necessary.

An applicant must:

• be a member of the Japanese Society of Toxicology
• be undergraduate or graduate student (except for adult graduate student) as of July 1, 2026
• be a presenter of poster presentation,
• be pre-registered for the Congress and complete the payment of registration fee by the deadline of abstract submission
• obtain a visa for entering Japan prior to the Congress, if necessary.

An applicant must:

• be a early-career toxicologists, including students
• be residing outside Japan
• be pre-registered for the Congress and complete the payment of registration fee by the deadline of abstract submission
• obtain a visa for entering Japan prior to the Congress, if necessary

The names of award winners will be announced during the Congress. The ceremony will take place on July 3, 2026 at the congress site. The award winners will receive a certificate and a prize.

*Please note that the duplicate applications with other awards are not permitted.

We are planning to make a PDF file of Program & Abstract Book and printed material of Program Book, not to make printed material of Program & Abstract Book. Printed material of Program Book will be distributed at the congress site.

The authors must submit abstract by themselves.
If you live in Japan, please register from the Japanese screen.
Click the "Go to Abstract Submission page" button on this page. We recommend you to register early, for the online submission system is likely to be heavily accessed as the deadline approaches.
Applicants registering for the first time are requested to make a new account entering their personal information first.
Read and follow the instruction on the screens, and fill in the required fields. The items you are required to fill in are as follows:

• Presenting author's personal information
• Name of authors (no more than 20 authors), affiliated institutions (no more than 15 institutions)
• Type of presentation (Oral/Poster/Either)
• Application for Excellent Presentation Award, Student Poster Award and JSOT International Poster Award (ONLY for poster presenters)
  *Please note that the duplicate applications with other awards are not permitted.
• Title of presentation (should be under 200 characters)
• Abstract body
  - It should be between 800-1600 characters (include spaces).
  - Do not include the title, names and institutions of authors.
  - It should NOT contain figure or table.
  - It must contain a brief, clear statement of conclusion.
• Category
  *Please select ONE.

  101	Pharmaceutical drugs (chemicals)
  102	Middle molecular drugs
  103	Biopharmaceuticals
  104	Regenerative medicine and cell therapy
  105	Agricultural chemicals
  106	Metals
  107	Industrial chemicals
  108	Toxins
  109	Foods, food additives, and food contaminants
  110	Environmental pollutants
  111	Endocrine disruptors
  112	Nanomaterials
  113	Radiation
  114	Other materials
  201	Nervous system
  202	Liver
  203	Kidney
  204	Skin
  205	Sensory organ
  206	Gastrointestinal system
  207	Respiratory system
  208	Cardio vascular system
  209	Reproductive system
  210	Endocrine system
  211	Other organs or system
  301	General toxicology
  302	Reproductive and developmental toxicology
  303	Genetic toxicology
  304	Carcinogenicity
  305	Behavioral toxicology

  306	Immunotoxicology
  307	Drug dependency
  308	Cytotoxicity
  309	Pharmacology
  310	Regulatory Science
  401	Oxidative stress
  402	Inflammation
  403	Mechanisms of toxicity
  404	Cellular response
  405	Molecular toxicology
  406	Gene regulation
  407	Epigenetics
  408	Omics
  409	Biomarkers
  410	Toxicity-testing methods
  411	Analytical method
  412	Toxicokinetics
  413	Toxicologic pathology
  414	Statistics
  415	Alternatives to mammalian models
  416	Animal model
  417	Epidemiology
  418	Clinical toxicology
  419	Hypersensitive subjects
  420	Risk assessment and communication
  421	Information technology, AI, and big data
  422	Organoid
  423	AOP（adverse outcome pathway）
  424	NAMs (New Approach Methods)
  500	Others

• COI disclosure

After finishing abstract submission, you will receive "notification message" to your registered e-mail address (ID) for confirmation. If you do not receive such an e-mail within 24 hours, please contact the Congress Management Office.

You can change/modify your abstract until the deadline of abstract submission by logging in to the Abstract Submission page.
After the deadline of the abstract submission, no modifications, changes, or additions whatsoever to the abstract body, authors (either first author or co-authors), or affiliations are permitted.
Please take great care to ensure that no mistakes are made before your submission.

Registered personal information use only for the annual meeting.
The information is protected and securely saved with necessary security.

The final decision to accept or reject the submitted abstracts will be made by the Organizing Committee. A notification of acceptance or rejection will be sent to each presenter by e-mail in April, 2026.

Firstly, please complete the early registration by the deadline of abstract submission.
Check the "Guide to Japanese VISA" through the URL below.
Ministry of Foreign Affairs of Japan (https://www.mofa.go.jp/j_info/visit/visa/index.html)
Please fill in the necessary documents for your VISA application and send by e-mail to the Congress Management Office. We will complete the documents and send back to you by mail.

Presenting authors must submit their abstracts by themselves.

Congress Management Office
E-mail: jsot53@senkyo.co.jp